Multi-Column Continuous Chromatography System and Automated Viral Inactivation System

Tender

Cell & Gene Therapy Catapult

Highlights

Tender deadline
17 Nov 2026
Estimated value
—
Location
—

Details

Published
22 Oct 2026
Tender deadline
17 Nov 2026
Value
—
Location
—
Source
Find a Tender
Source notice ID
100022-2026
OCID
ocds-h6vhtk-078e00
CPV codes
33100000, 33197000, 35810000, 38000000
View on Find a Tender

Description

CGTC are looking for the purchase and installation of a multi-column chromatography system (MCCS) and a viral inactivation hardware system with related services e.g service, repair and maintenance contract, training and consumables for our Braintree Essex site. both systems will be system applicable for biopharmaceutical production.

For more information about this opportunity, please visit the eSourcing portal at:

https://www.delta-esourcing.com/tenders/UK-UK-London:-Medical-equipments./6CCRCYB2WJ

To respond to this opportunity, please click here:

https://www.delta-esourcing.com/respond/6CCRCYB2WJ

Similar opportunities

More from Cell & Gene Therapy Catapult

View all

Lots (2)

LotTitleValue
1Multi-column Continuous Chromatography SystemLot 1 - Multi-column Continuous Chromatography System CGTC are looking for the purchase and installation of a multi-column chromatography system (MCCS) and related services e.g service, repair and maintenance contract, training and consumables for our Braintree Essex site. The instrument will be a fully automated chromatography system applicable for biopharmaceutical production. The main key feature of the multi-column chromatography technology is the use of a series of interconnected columns allowing the first column to reach breakthrough during loading which significantly improves the utilisation of the chromatographic resin or membrane. A typical application of the technology is for capture chromatography however it is not limited to it.—
2Viral Inactivation Hardware SystemViral Inactivation Hardware System he system must provide automated viral inactivation processing including the following steps: a) controlled mixing b) pH measurement e.g. via probe or single-use sensor integrated into single-use bioprocessing vessel and/or tubing set c) automated pH adjustment e.g via dosing pumps d) batch execution control e.g. via programmable software or HMI screen e) GMP batch data capture f) product vessel volume/mass monitoring e.g. via load cells g) temperature control of liquid product contained in single-use bioprocessing vessel and/or tubing set h) temperature monitoring of liquid product contained in single-use bioprocessing vessel and/or tubing set—